BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10880255)

  • 21. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
    Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
    Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
    Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
    Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta1 impairs homocysteine metabolism in human renal cells: possible implications for transplantation.
    Sengoelge G; Kletzmayr J; Papagiannopoulos M; Bohle B; Hörl WH; Födinger M; Sunder-Plassmann G
    Transpl Int; 2003 Dec; 16(12):843-8. PubMed ID: 12897987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
    Zhu S; Liu Y; Wang L; Meng QH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats.
    Hiong LC; Voon KL; Abdullah NA; Sattar MA; Rahman NA; Khan AH; Johns EJ
    Acta Pharmacol Sin; 2008 Apr; 29(4):451-7. PubMed ID: 18358091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change of plasma transforming growth factor-beta1 levels in nasopharyngeal carcinoma patients treated with concurrent chemo-radiotherapy.
    Chen HW; Chang YC; Lai YL; Chen YJ; Huang MJ; Leu YS; Fu YK; Wang LW; Hwang JJ
    Jpn J Clin Oncol; 2005 Aug; 35(8):427-32. PubMed ID: 16006572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma TGF-beta1 as a risk factor for gingival overgrowth.
    Ellis JS; Morgan CL; Kirby JA; Taylor JJ; Thomason JM
    J Clin Periodontol; 2004 Oct; 31(10):863-8. PubMed ID: 15367190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
    Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
    J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of transforming growth factor beta1 on long-term renal allograft function].
    Wang PX; Fan MQ; Huang CB; Zhnag GF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1352-5. PubMed ID: 16982454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum TGF-beta 1 and TNF-alpha levels and cardiac fibrosis in experimental chronic renal failure.
    Fedulov AV; Ses TP; Gavrisheva NA; Rybakova MG; Vassilyeva JG; Tkachenko SB; Kallner A; MacMillan JC
    Immunol Invest; 2005; 34(2):143-52. PubMed ID: 15921156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between TGF-Beta1 in allograft and chronic allograft nephropathy].
    Wang PX; Fan MQ; Gong GZ; Xu HY; Huang CB; Zhang GT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):112-4, 122. PubMed ID: 16468656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
    Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
    Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
    Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy.
    Yu HM; Liu YF; Cheng YF; Hu LK; Hou M
    Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S; Nyengaard JR; Wogensen L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
    Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
    Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta1 in patients with renal cell carcinoma.
    Hegele A; Varga Z; von Knobloch R; Heidenreich A; Kropf J; Hofmann R
    Urol Res; 2002 May; 30(2):126-9. PubMed ID: 12086018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma TGF-beta 1 level in patient with salivary gland carcinoma after renal transplantation.
    Boratyńska M; Watorek E; Falkiewicz K; Banasik M
    Ann Transplant; 2005; 10(2):16-9. PubMed ID: 16218027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The correction of the immune disorders in patients with chronic pyelonephritis and chronic kidney failure].
    Neĭmark AI; Iakovets IaV
    Urol Nefrol (Mosk); 1994; (5):22-4. PubMed ID: 7532880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.